American Society of Haematology
As rituximab biosimilars close in, Roche showcases Gazyva superiority
Andrew McConaghie
American Society of Haematology, ASH, biosimilars, Haematology
0 Comment
Roche faces competition against its blockbuster haematology drug
X
As rituximab biosimilars close in, Roche showcases Gazyva superiority
https://pharmaphorum.com/news/rituximab-biosimilars-close-roche-showcases-gazyva-superiority/